Published in Neuroscience on January 15, 2011
Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J Neuroendocrinol (2012) 1.63
Renal response to vasopressin after inhibition of prostaglandin synthesis. Am J Physiol (1977) 1.11
Differential expression of GL7 activation antigen on bone marrow B cell subpopulations and peripheral B cells. Immunol Lett (2001) 1.09
The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience (1999) 1.03
Two distinct alpha1-adrenergic receptor sites in rat liver: differential binding of (--)-[3H]dihydroergocryptine. Effects of guanine nucleotides and proteolysis; implications for a two-site model of alpha-receptor regulation. Biochem Pharmacol (1981) 0.98
Terminal deletion 6p23: a case report. Am J Med Genet (1990) 0.98
The kappa-opioid receptor: evidence for the different subtypes. Life Sci (1993) 0.96
CD and Fourier transform ir spectroscopic studies of peptides. II. Detection of beta-turns in linear peptides. Biopolymers (1994) 0.95
Agonist-induced signaling and trafficking of the mu-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain. FEBS Lett (1997) 0.94
Caveolin-1 is transported to multi-vesicular bodies after albumin-induced endocytosis of caveolae in HepG2 cells. J Cell Mol Med (2007) 0.93
Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays. Eur J Pharmacol (1999) 0.92
In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance. Br J Pharmacol (2007) 0.91
Development of delta-opioid receptor subtypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridization studies. J Pharmacol Exp Ther (1995) 0.86
Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series. Eur J Pharmacol (1993) 0.86
Inactivation of alpha- and beta-thrombin by antithrombin-III, alpha 2-macroglobulin and alpha 1-proteinase inhibitor. Biochem J (1977) 0.85
Characterization of kappa 1 and kappa 2 opioid binding sites in frog (Rana esculenta) brain membrane preparation. Neurochem Res (1990) 0.85
Covalent labeling of opioid receptors with 3H-D-Ala2-Leu5-enkephalin chloromethyl ketone. I. Binding characteristics in rat brain membranes. Life Sci (1987) 0.83
Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans. Life Sci (1999) 0.83
Esophageal tonsil: a novel gut-associated lymphoid organ. Poult Sci (2003) 0.83
Structure and function of G protein coupled receptors. Pharm Res (1990) 0.83
Solubilization and characterization of opioid binding sites from frog (Rana esculenta) brain. J Neurochem (1984) 0.82
Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids. Neurochem Res (1998) 0.82
Modulation of opioid binding associated with nuclear matrix and nuclear membranes of NG108-15 cells. J Pharmacol Exp Ther (1995) 0.82
Nociceptin inhibits uterine contractions in term-pregnant rats by signaling through multiple pathways. Biol Reprod (2010) 0.81
A patient with tetrasomy 9p, Dandy-Walker cyst and Hirschsprung disease. Ann Genet (1992) 0.81
Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone: a mu specific affinity label for the opioid receptor. Neuropeptides (1987) 0.81
Multimodality treatment of pancreatic pseudoaneurisms. Acta Chir Hung (1997) 0.81
Inactivation of alpha- and beta- thrombin by antithrombin-III and heparin. Thromb Haemost (1976) 0.81
Functional restoration of the bursa of Fabricius following in ovo infectious bursal disease vaccination. Vet Immunol Immunopathol (2001) 0.81
Nociceptin binding sites in frog (Rana esculenta) brain membranes. Biochem Biophys Res Commun (1999) 0.80
Oesophageal tonsil of the chicken. Acta Vet Hung (2005) 0.80
Origin of the bursal secretory dendritic cell. Anat Embryol (Berl) (2004) 0.80
Duplication 4p and deletion 4p (Wolf-Hirschhorn syndrome) due to complementary gametes from a 3:1 segregation of a maternal balanced t(4;13)(p16;q11) translocation. Am J Med Genet A (2004) 0.80
Identification of the avian B-cell-specific Bu-1 alloantigen by a novel monoclonal antibody. Poult Sci (2008) 0.80
In vitro binding and signaling profile of the novel mu opioid receptor agonist endomorphin 2 in rat brain membranes. Biochem Biophys Res Commun (1998) 0.79
Specific activation of the mu opioid receptor (MOR) by endomorphin 1 and endomorphin 2. Eur J Neurosci (2000) 0.79
Effect of gonadectomy on pituitary levels of mRNA encoding gonadotropin subunits and secretion of luteinizing hormone. Mol Cell Endocrinol (1984) 0.79
The fibrin-derived citrullinated peptide β60-74Cit₆₀,₇₂,₇₄ bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies. Ann Rheum Dis (2013) 0.79
Cell-free translation of the rat pituitary messenger RNA coding for the precursors of alpha and beta subunits of lutropin. FEBS Lett (1981) 0.79
Selective protection of benzomorphan binding sites against inactivation by N-ethylmaleimide. Evidence for kappa-opioid receptors in frog brain. J Neurochem (1988) 0.79
Synthesis and binding characteristics of [3H] H-Tyr-Ticpsi[CH2-NH] Cha-Phe-OH, a highly specific and stable delta-opioid antagonist. Peptides (1999) 0.78
Mu-receptor specificity of the opioid peptide irreversible reagent, [3H]DALECK. Neuropeptides (1987) 0.78
Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy. Eur J Pharmacol (2001) 0.78
Kinetics and physical parameters of rat brain opioid receptors solubilized by digitonin and CHAPS. J Neurochem (1986) 0.78
The occurrence of different kappa opioid receptors (K1 and K2) in frog (Rana esculenta) brain membranes. Acta Physiol Hung (1990) 0.78
Species differences in the stereoselectivity of kappa opioid binding sites for [3H]U-69593 and [3H]ethylketocyclazocine. Life Sci (1992) 0.78
Restraint stress and anti-tumor immune response in mice. Acta Biol Hung (2003) 0.78
Side chain modifications change the binding and agonist properties of endomorphin 2. Biochem Biophys Res Commun (2002) 0.78
Prenatal fate of parthenogenetic cells in mouse aggregation chimaeras. Development (1987) 0.78
Estradiol regulates mRNAs encoding precursors to rat lutropin (LH) and follitropin (FSH) subunits. Biochem Biophys Res Commun (1983) 0.78
Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA. Antisense Nucleic Acid Drug Dev (1999) 0.78
Binding characteristics of the novel highly selective delta agonist, [3H]IIe5,6deltorphin II. Neuropeptides (1994) 0.78
A novel monoclonal antibody identifies all avian embryonic myogenic cells and adult smooth muscle cells. Anat Embryol (Berl) (2001) 0.78
Immunoprecipitation studies of monoclonal antibodies submitted to the Second International Swine CD Workshop. Vet Immunol Immunopathol (1998) 0.77
Synthesis and binding of 3H-oxymorphazone to rat brain membranes. Life Sci (1987) 0.77
Binding characteristics and analgesic activity of D-ALA2-Leu5-enkephalin chloromethyl ketone. Life Sci (1983) 0.77
Estrogen-like effects of 7,12-dimethylbenz(a)anthracene on the female rat hypothalamo-pituitary axis. J Steroid Biochem (1990) 0.77
Method for isolation of kappa-opioid binding sites by dynorphin affinity chromatography. J Neurosci Res (1990) 0.77
The hepatic alpha-adrenergic receptor. Adv Cyclic Nucleotide Res (1981) 0.77
New nepenthone and thevinone derivatives. Bioorg Med Chem (1997) 0.77
Primary meningeal melanocytoma of the pineal region. Case report. J Neurosurg (2000) 0.77
Uncoupling by proteolysis of alpha-adrenergic receptor-mediated inhibition of adenylate cyclase in human platelets. Biochem Biophys Res Commun (1982) 0.77
Radioligand binding properties of VV-hemorphin 7, an atypical opioid peptide. Biochem Biophys Res Commun (2001) 0.77
Detailed analysis of heterogeneity of [3H]naloxone binding sites in rat brain synaptosomes. Neurochem Res (1987) 0.77
Characterization of N,N(Me)2-Dmt-Tic-OH, a delta selective opioid dipeptide antagonist. Neuroreport (2000) 0.77
Characterization of [3H]Met-enkephalin-Arg6-Phe7 binding to opioid receptors in frog brain membrane preparations. J Neurochem (1994) 0.77
Purification of a kappa-opioid receptor subtype from frog brain. Neuropeptides (1987) 0.77
A monoclonal antibody recognizing kappa- but not mu- and delta-opioid receptors. J Neurochem (1991) 0.76
Altered gene expression and functional activity of opioid receptors in the cerebellum of CB1 cannabinoid receptor knockout mice after acute treatments with cannabinoids. Acta Biol Hung (2007) 0.76
Tritiated kappa receptor antagonist norbinal torphimine: synthesis and in vitro binding in three different tissues. Life Sci (2000) 0.76
Effects of oxymorphazone in frogs: long lasting antinociception in vivo, and apparently irreversible binding in vitro. Life Sci (1989) 0.76
Weaning-induced development of delta-opioid receptors in rat brain: differential effects of guanine nucleotides and sodium upon ligand-receptor recognition. Br J Pharmacol (1998) 0.76
Promitogenic effects of ethanol, methanol, and ethanolamine in insulin-treated fibroblasts. Biochem Pharmacol (2000) 0.76
Long-lasting antinociceptive effect of DAMGO chloromethyl ketone in rats. Peptides (1999) 0.76
Stereoselective effect of warfarin and bilirubin on the binding of 5-(o-chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-2H-1,4-benzodiazepin-2- one enantiomers to human serum albumin. Chirality (1990) 0.76
Irreversible blockade of the high and low affinity (3H) naloxone binding sites by C-6 derivatives of morphinane-6-ones. Life Sci (1991) 0.76
Proteolysis of rat liver plasma membranes cancels the guanine nucleotide sensitivity of agonist binding to the alpha-adrenoceptor. Biochem Biophys Res Commun (1980) 0.76
Characterization of rat brain opioid receptors by [Tyr-3,5-3H]1, D-Ala2, Leu5-enkephalin binding. Neurochem Res (1985) 0.76
Affinity labelling of frog brain opioid receptors by dynorphin(1-10) chloromethyl ketone. Neuropeptides (1997) 0.75
Binding studies of novel, non-mammalian enkephalins, structures predicted from frog and lungfish brain cDNA sequences. Neuroscience (2008) 0.75
Synthesis and binding characteristics of the highly delta-specific new tritiated opioid peptide, [3H]deltorphin II. Life Sci (1992) 0.75
Increased lysosomal fragility in the human uterine cervix following estrogen therapy. Arch Gynecol (1985) 0.75
Separation of kappa-opioid receptor subtype from frog brain. FEBS Lett (1985) 0.75
Synthesis and binding characteristics of tritiated TIPP[psi], a highly specific and stable delta opioid antagonist. Life Sci (1995) 0.75